Bibliotecas PUC-SP - Busca Integrada

Targeting the androgen receptor pathway in prostate cancer

Por Chen, Yu, Sawyers, Charles L., Scher, Howard I.
Publicado em 2008

Setting the bar in Phase II trials: the use of historical data for determining “go / no go” decision for definitive phase III testing

Por Vickers, Andrew J., Ballen, Vennus, Scher, Howard I.
Publicado em 2007

Prostate Cancer Clinical Trial End Points: ‘‘RECIST’’ing a Step Backwards

Por Scher, Howard I., Morris, Michael J., Kelly, William K., Schwartz, Lawrence H., Heller, Glenn
Publicado em 2005

Assessing Outcomes in Prostate Cancer Clinical Trials: A 21st Century Tower of Babel

Por Gignac, Gretchen A., Morris, Michael J., Heller, Glenn, Schwartz, Lawrence H., Scher, Howard I.
Publicado em 2008

The Natural History of Noncastrate Metastatic Prostate Cancer after Radical Prostatectomy

Por Yossepowitch, Ofer, Bianco, Fernando J., Eggener, Scott E., Eastham, James A., Scher, Howard I., Scardino, Peter T.
Publicado em 2006

The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin

Por Butler, Lisa M., Zhou, Xianbo, Xu, Wei-Sheng, Scher, Howard I., Rifkind, Richard A., Marks, Paul A., Richon, Victoria M.
Publicado em 2002

Imaging Therapeutic Response in Human Bone Marrow Using Rapid Whole-Body MRI

Por Ballon, Douglas, Watts, Richard, Dyke, Jonathan P., Lis, Eric, Morris, Michael J., Scher, Howard I., Ulug, Aziz M., Jakubowski, Ann A.
Publicado em 2004

Induction of autoantibodies to syngeneic prostate-specific membrane antigen by xenogeneic vaccination

Por Gregor, Polly D., Wolchok, Jedd D., Turaga, Vandana, Latouche, Jean-Baptiste, Sadelain, Michel, Bacich, Dean, Heston, Warren D.W., Houghton, Alan N., Scher, Howard I.
Publicado em 2005

Phase 1 Trial of High-Dose Exogenous Testosterone in Patients with Castration-Resistant Metastatic Prostate Cancer

Por Morris, Michael J., Huang, Daisy, Kelly, William K., Slovin, Susan F., Stephenson, Ryan D., Eicher, Caitlin, Delacruz, Anthony, Curley, Tracy, Schwartz, Lawrence, Scher, Howard I.
Publicado em 2009

Antibody mass escalation study in patients with castration resistant prostate cancer using (111)I-J591: Lesion detectability and dosimetric projections for (90)Y radioimmunotherapy

Por Pandit-Taskar, Neeta, O’Donoghue, Joseph A., Morris, Michael J, Wills, Eze A., Schwartz, Lawrence H., Gonen, Mithat, Scher, Howard I., Larson, Steven M., Divgi, Chaitanya R.
Publicado em 2008

Fluorodeoxyglucose Positron Emission Tomography as an Outcome Measure for Castrate Metastatic Prostate Cancer Treated with Antimicrotubule Chemotherapy

Por Morris, Michael J., Akhurst, Timothy, Larson, Steven M., Ditullio, Marisa, Chu, Elaina, Siedlecki, Karen, Verbel, David, Heller, Glenn, Kelly, W. Kevin, Slovin, Susan, Schwartz, Lawrence, Scher, Howard I.
Publicado em 2005

Evaluation of an Online Platform for Cancer Patient Self-reporting of Chemotherapy Toxicities

Por Basch, Ethan, Artz, David, Iasonos, Alexia, Speakman, John, Shannon, Kevin, Lin, Kai, Pun, Charmaine, Yong, Henry, Fearn, Paul, Barz, Allison, Scher, Howard I., McCabe, Mary, Schrag, Deborah
Publicado em 2007

A Novel Androgen Receptor Amino Terminal Region Reveals Two Classes of Amino/Carboxyl Interaction-Deficient Variants with Divergent Capacity to Activate Responsive Sites in Chromat...

Por Need, Eleanor F., Scher, Howard I., Peters, Amelia A., Moore, Nicole L., Cheong, Albert, Ryan, Charles J., Wittert, Gary A., Marshall, Villis R., Tilley, Wayne D., Buchanan, Grant
Publicado em 2009

NF-κB Regulates Androgen Receptor Expression and Prostate Cancer Growth

Por Zhang, Liying, Altuwaijri, Saleh, Deng, Fangming, Chen, Lishi, Lal, Priti, Bhanot, Umeshkumar K., Korets, Ruslan, Wenske, Sven, Lilja, Hans G., Chang, Chawnshang, Scher, Howard I., Gerald, William L.
Publicado em 2009

Pattern of Prostate-Specific Antigen (PSA) Failure Dictates the Probability of a Positive Bone Scan in Patients With an Increasing PSA After Radical Prostatectomy

Por Dotan, Zohar A., Bianco, Fernando J., Rabbani, Farhang, Eastham, James A., Fearn, Paul, Scher, Howard I., Kelly, Kevin W., Chen, Hui-Ni, Schöder, Heiko, Hricak, Hedvig, Scardino, Peter T., Kattan, Michael W.
Publicado em 2005

Identification of novel androgen receptor target genes in prostate cancer

Por Jariwala, Unnati, Prescott, Jennifer, Jia, Li, Barski, Artem, Pregizer, Steve, Cogan, Jon P, Arasheben, Armin, Tilley, Wayne D, Scher, Howard I, Gerald, William L, Buchanan, Grant, Coetzee, Gerhard A, Frenkel, Baruch
Publicado em 2007

Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis

Por Chen, Zhenbang, Trotman, Lloyd C., Shaffer, David, Lin, Hui-Kuan, Dotan, Zohar A., Niki, Masaru, Koutcher, Jason A., Scher, Howard I., Ludwig, Thomas, Gerald, William, Cordon-Cardo, Carlos, Pandolfi, Pier Paolo
Publicado em 2005

Identification of novel androgen receptor target genes in prostate cancer

Por Gerald William L, Scher Howard I, Arasheben Armin, Tilley Wayne D, Cogan Jon P, Pregizer Steve, Barski Artem, Jia Li, Prescott Jennifer, Jariwala Unnati, Buchanan Grant, Coetzee Gerhard A, Frenkel Baruch
Publicado no Molecular Cancer (2007-06-01)

Differential exoprotease activities confer tumor-specific serum peptidome patterns

Por Villanueva, Josep, Shaffer, David R., Philip, John, Chaparro, Carlos A., Erdjument-Bromage, Hediye, Olshen, Adam B., Fleisher, Martin, Lilja, Hans, Brogi, Edi, Boyd, Jeff, Sanchez-Carbayo, Marta, Holland, Eric C., Cordon-Cardo, Carlos, Scher, Howard I., Tempst, Paul
Publicado em 2006

Phase I Study of Samarium-153 Lexidronam With Docetaxel in Castration-Resistant Metastatic Prostate Cancer

Por Morris, Michael J., Pandit-Taskar, Neeta, Carrasquillo, Jorge, Divgi, Chaitanya R., Slovin, Susan, Kelly, William K., Rathkopf, Dana, Gignac, Gretchen A., Solit, David, Schwartz, Lawrence, Stephenson, Ryan D., Hong, Christina, Delacruz, Anthony, Curley, Tracy, Heller, Glenn, Jia, Xiaoyu, O'Donoghue, Joseph, Larson, Steven, Scher, Howard I.
Publicado em 2009